NATION
Vicki L. Sato, vice president-research, will replace Richard A. Flavell as head of research at Biogen, a biotechnology firm with headquarters in Cambridge, Mass. Sato has also been appointed to the company’s scientific board. Flavell has been appointed chairman of the section of immunobiology at Yale University and investigator in the Howard Hughes Medical Institute.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
